We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+10.66%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$1.55B
AUM Growth
+$380M
Cap. Flow
+$243M
Cap. Flow %
15.72%
Top 10 Hldgs %
50.51%
Holding
57
New
12
Increased
9
Reduced
9
Closed
12

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$72.8M
2
HCA icon
HCA Healthcare
HCA
+$69.8M
3
BKD icon
Brookdale Senior Living
BKD
+$48.5M
4
THC icon
Tenet Healthcare
THC
+$32.8M
5
DGX icon
Quest Diagnostics
DGX
+$25.6M

Top Sells

Rank Stock Value
1
CYBX
CYBERONICS INC
CYBX
+$60.8M
2
ESRX
Express Scripts Holding Company
ESRX
+$48.6M
3
CCRN
Cross Country Healthcare
CCRN
+$20.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$20.1M
5
HMSY
HMS Holdings Corp.
HMSY
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 65.24%
2 Consumer Staples 2.55%
3 Technology 2.52%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
26
PTC Therapeutics
PTCT
$5.68B
$16.2M 1.05%
+500,000
New +$14.7M
PLX icon
27
Protalix BioTherapeutics
PLX
$191M
$13.5M 0.88%
1,327,500
+600,042
+82% +$6.1M
LDRH
28
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$13.4M 0.87%
+533,400
New +$13.9M
DRRX
29
DELISTED
DURECT Corp
DRRX
$13.3M 0.86%
600,000
– –
OSUR icon
30
OraSure Technologies
OSUR
$279M
$12.9M 0.83%
2,000,000
– –
ELOS
31
DELISTED
Syneron Medical Ltd
ELOS
$11.6M 0.75%
+1,505,700
New +$11.5M
OPCH icon
32
Option Care Health
OPCH
$3.45B
$10.5M 0.68%
1,500,000
– –
ATXS
33
DELISTED
Astria Therapeutics
ATXS
$7.93M 0.51%
16,667
– –
EPRS
34
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$5.71M 0.37%
1,847,500
– –
GNMK
35
DELISTED
GenMark Diagnostics, Inc
GNMK
$5.04M 0.33%
649,097
-75,000
-10% -$576K
BIOL
36
DELISTED
Biolase, Inc.
BIOL
$4.49M 0.29%
427
– –
ANGO icon
37
AngioDynamics
ANGO
$611M
$2.95M 0.19%
243,183
-15,000
-6% -$185K
UNIS
38
DELISTED
Unilife Corporation
UNIS
$1.36M 0.09%
275,000
– –
CRDC
39
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$1.3M 0.08%
837,485
– –
XLV icon
40
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$1.2M 0.08%
+16,700
New +$1.18M
ABT icon
41
Abbott
ABT
$183B
– –
-300,000
Closed -$12.1M
ALNY icon
42
Alnylam Pharmaceuticals
ALNY
$27.5B
– –
-250,000
Closed -$20.1M
AMRN
43
Amarin Corp
AMRN
$299M
– –
-325,000
Closed -$12.5M
AZN icon
44
CALL
AstraZeneca
AZN
$263B
– –
-920,587
Closed -$3K
CCRN
45
DELISTED
Cross Country Healthcare
CCRN
– –
-1,493,765
Closed -$20.3M
GYRE icon
46
Gyre Therapeutics
GYRE
$641M
– –
-1,715
Closed -$899K
PODD icon
47
Insulet
PODD
$11.5B
– –
-245,000
Closed -$6.35M
VCYT icon
48
Veracyte
VCYT
$3.7B
– –
-910,334
Closed -$4.27M
HMSY
49
DELISTED
HMS Holdings Corp.
HMSY
– –
-2,179,900
Closed -$19.1M
ESRX
50
DELISTED
Express Scripts Holding Company
ESRX
– –
-600,000
Closed -$48.6M
1
2
3

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Camber Capital Management held 57 positions worth $1.55B, up 33% from $1.17B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Camber Capital Management deployed $243M of net new capital in Q4 2015, opening 12 new positions and adding to 9 existing holdings. Its largest new stake was LivaNova: 1,200,000 shares worth $71.2M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, down from 72% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was AstraZeneca, an estimated $16.4M trimmed.

  • Camber Capital Management's largest Q4 2015 buy was LivaNova: 1,200,000 shares worth $71.2M.
  • Camber Capital Management added most to Tenet Healthcare in Q4 2015, an estimated $32.8M increase.
  • Camber Capital Management's biggest Q4 2015 reduction was AstraZeneca, cutting an estimated $16.4M.
  • Camber Capital Management fully exited CYBERONICS INC in Q4 2015, selling an estimated $60.8M.
  • Camber Capital Management's ten largest holdings make up 51% of its $1.55B portfolio in Q4 2015.
  • Camber Capital Management opened 12 new positions and closed 12 in Q4 2015.
  • Camber Capital Management's portfolio value rose 33% quarter-over-quarter to $1.55B.

Based on Camber Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.